SEC Tracker
Get the app

Surrozen SRZN

Surrozen Chief Executive Officer Craig Parker reported purchasing 50,000 shares of SRZNW common stock for a total transaction value of $250,000. This insider buying activity signals a bullish sentiment from the company's top executive, suggesting they are confident in Surrozen's future prospects.

Andrew Pedrum Maleki, insider filing for SRZN

Form
4
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when Surrozen files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Sutro Biopharma STRO public float $60M, Jun 30, 2025
  2. PDS Biotechnology PDSB public float $60M, Jun 30, 2025
  3. iBio IBIO public float $58M, Dec 31, 2025
  4. Medicinova MNOV public float $62M, Jun 30, 2025
  5. Lifevantage LFVN public float $64M, Dec 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.